Goljan High Yield
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
---|---|---|---|---|---|
show | driving force for diffusion of O2 into tissue
🗑
|
||||
show | percent heme groups occupied by O2
🗑
|
||||
show | decreased O2 saturation (SaO2); O2 content
🗑
|
||||
show | electron acceptor in oxidative pathway
🗑
|
||||
Hypoxia | show 🗑
|
||||
show | decreased arterial (or venous) blood flow
🗑
|
||||
Respiratory acidosis | show 🗑
|
||||
show | impaired delivery of O2 to alveoli; intrapulmonary shunting of blood (e.g., RDS)
🗑
|
||||
Perfusion defect | show 🗑
|
||||
Diffusion defect | show 🗑
|
||||
show | ↓ SaO2; heme Fe+3; oxidizing agents (sulfur/nitro drugs); Rx with IV methylene blue
🗑
|
||||
show | cyanosis not corrected by O2; chocolate colored blood
🗑
|
||||
show | ↓ SaO2; left-shift O2 binding curve; inhibits cytochrome oxidase
🗑
|
||||
Causes carbon monoxide poisoning | show 🗑
|
||||
show | headache; cherry red color skin
🗑
|
||||
Cyanide | show 🗑
|
||||
show | house fires
🗑
|
||||
show | ↓ 2, 3 BPG, carbon monoxide, alkalosis, HbF, methemoglobin, hypothermia
🗑
|
||||
Right-shifted O2 curve | show 🗑
|
||||
show | respiratory alkalosis enhances glycolysis; ↑ synthesis 2,3 BPG
🗑
|
||||
show | damages membrane and drains off protons; alcohol, salicylates
🗑
|
||||
show | drain off protons; dinitrophenol, thermogenin (brown fat)
🗑
|
||||
Complication mitochondrial poisons/uncoupling agents | show 🗑
|
||||
show | impaired Na+/K+ ATPase pump (cellular swelling); reversible
🗑
|
||||
show | ATP synthesis in hypoxia; lactate ↓ intracellular pH, denatures proteins
🗑
|
||||
Irreversible injury hypoxia | show 🗑
|
||||
Mitochondrial damage | show 🗑
|
||||
Irreversible injury hypoxia | show 🗑
|
||||
show | unpaired electron in outer orbit; damage cell membranes and DNA
🗑
|
||||
Free radicals | show 🗑
|
||||
Superoxide dismutase | show 🗑
|
||||
show | neutralizes peroxide, drug FRs
🗑
|
||||
Catalase | show 🗑
|
||||
Lipofuscin | show 🗑
|
||||
Reperfusion injury in heart | show 🗑
|
||||
show | cytochrome c in cytosol initiates apoptosis
🗑
|
||||
SER hyperplasia | show 🗑
|
||||
Complications SER hyperplasia | show 🗑
|
||||
Chediak-Higashi | show 🗑
|
||||
show | AR; giant lysosomes
🗑
|
||||
show | absent enzyme marker in Golgi apparatus (mannose 6-phosphate); empty lysosomes
🗑
|
||||
show | stiff muscles after death due to ATP depletion
🗑
|
||||
show | MCC alcohol (increase in NADH); DHAP → G3P → TG
🗑
|
||||
show | VLDL pushes nucleus to side
🗑
|
||||
Causes fatty change | show 🗑
|
||||
Fatty change in kwashiorkor | show 🗑
|
||||
show | primary iron storage protein; soluble in blood; serum level reflects marrow storage iron
🗑
|
||||
Hemosiderin | show 🗑
|
||||
show | reduction in cell/tissue mass by either loss or cell shrinkage
🗑
|
||||
Brain atrophy | show 🗑
|
||||
Exocrine gland atrophy in CF | show 🗑
|
||||
show | stem cells (skin, marrow, GI tract) →←→⇦
🗑
|
||||
Stable cells | show 🗑
|
||||
show | cannot replicate; cardiac/striated muscle; neurons
🗑
|
||||
Hypertrophy | show 🗑
|
||||
LVH | show 🗑
|
||||
show | pulmonary hypertension
🗑
|
||||
show | prostate hyperplasia constricts urethra
🗑
|
||||
show | hypertrophy of remaining kidney
🗑
|
||||
show | increase in number of cells
🗑
|
||||
Endometrial hyperplasia | show 🗑
|
||||
RBC hyperplasia | show 🗑
|
||||
show | increased dihydrotestosterone (DHEA)
🗑
|
||||
show | hyperplasia male breast tissue; normal in newborn, adolescent, elderly
🗑
|
||||
show | one adult cell type replaces another cell type
🗑
|
||||
show | smoking
🗑
|
||||
Intestinal metaplasia in stomach | show 🗑
|
||||
Squamous metaplasia bladder | show 🗑
|
||||
show | glandular metaplasia of distal esophagus; due to GERD
🗑
|
||||
Dysplasia | show 🗑
|
||||
show | human papilloma virus
🗑
|
||||
show | smoking
🗑
|
||||
show | death of groups of cells
🗑
|
||||
show | preservation of structural outline (due to ↑ lactic acid)
🗑
|
||||
Infarction | show 🗑
|
||||
show | brain infarct, bacterial infections; wet gangrene
🗑
|
||||
show | variant coagulation necrosis; granulomas due to TB/systemic fungi
🗑
|
||||
Granulomas | show 🗑
|
||||
Epithelioid cells | show 🗑
|
||||
show | fusion of epithelioid cells
🗑
|
||||
show | type IV hypersensitivity
🗑
|
||||
Enzymatic fat necrosis | show 🗑
|
||||
Fibrinoid necrosis | show 🗑
|
||||
Postmortem necrosis | show 🗑
|
||||
Dystrophic calcification | show 🗑
|
||||
Dystrophic calcification | show 🗑
|
||||
show | calcification of normal tissue; increased serum calcium or phosphorus
🗑
|
||||
show | metastatic calcification of collecting tubule basement membranes
🗑
|
||||
S/S nephrocalcinosis | show 🗑
|
||||
Apoptosis | show 🗑
|
||||
Signals activating apoptosis | show 🗑
|
||||
show | TP53 suppressor gene, BCL-2 genes
🗑
|
||||
show | anti-apoptosis gene; prevents cytochrome c from leaving mitochondria
🗑
|
||||
Caspases | show 🗑
|
||||
Markers of apoptosis | show 🗑
|
||||
show | loss Mullerian epithelium in male fetus; thymus involution; killing cancer cells
🗑
|
||||
show | key chemical in acute inflammation; mast cell; arteriole vasodilation; ↑ venular permeability
🗑
|
||||
Rubor acute inflammation | show 🗑
|
||||
show | heat; arteriole vasodilation (histamine)
🗑
|
||||
Tumor acute inflammation | show 🗑
|
||||
show | pain; bradykinin, PGE
🗑
|
||||
show | neutrophil dominant; ↑ IgM
🗑
|
||||
show | transient vasoconstriction → arteriolar vasodilation → ↑ venular permeability
🗑
|
||||
show | due to selectins
🗑
|
||||
Integrins | show 🗑
|
||||
CD11/CD18 | show 🗑
|
||||
show | activated by IL-1 and TNF
🗑
|
||||
ICAM | show 🗑
|
||||
VCAM | show 🗑
|
||||
show | neutrophilic leukocytosis; corticosteroids
🗑
|
||||
Activation neutrophil adhesion molecules | show 🗑
|
||||
Chemotaxis | show 🗑
|
||||
show | IgG, C3b; enhance phagocytosis
🗑
|
||||
Neutrophils, monocytes, macrophages | show 🗑
|
||||
O2-dependent MPO system | show 🗑
|
||||
show | NADPH oxidase with NADPH cofactor; produces respiratory burst
🗑
|
||||
show | test for respiratory burst
🗑
|
||||
show | converts superoxide to peroxide
🗑
|
||||
show | lysosomal enzyme that combines peroxide + Cl to form bleach (HOCl)
🗑
|
||||
show | chronic granulomatous disease childhood (XR), myeloperoxidase deficiency (AR)
🗑
|
||||
show | absent NADPH oxidase; no respiratory burst
🗑
|
||||
show | Staphylococcus aureus not killed (catalase positive)
🗑
|
||||
Chronic granulomatous disease | show 🗑
|
||||
Myeloperoxidase deficiency | show 🗑
|
||||
Opsonization defect | show 🗑
|
||||
show | Chediak-Higashi (see cell injury); also has defect in microtubule polymerization
🗑
|
||||
COX inhibitors | show 🗑
|
||||
show | vasodilation, fever
🗑
|
||||
PGI2 | show 🗑
|
||||
Nitric oxide | show 🗑
|
||||
show | fever, synthesis acute phase reactants in liver, leukocytosis
🗑
|
||||
show | stimulated by IL-1; stimulates synthesis of acute phase reactants
🗑
|
||||
Acute phase reactants | show 🗑
|
||||
Bradykinin | show 🗑
|
||||
Bradykinin | show 🗑
|
||||
show | C3a and C5a; directly stimulate mast cell release of histamine
🗑
|
||||
Prostaglandin I2 | show 🗑
|
||||
show | hydroxylation of arachidonic acid
🗑
|
||||
Zileuton | show 🗑
|
||||
Zafirlukast, montelukast | show 🗑
|
||||
LTC4, -D4, -E4 | show 🗑
|
||||
TXA2 | show 🗑
|
||||
show | inhibits thromboxane synthase
🗑
|
||||
Corticosteroids | show 🗑
|
||||
show | neutrophilic leukocytosis, lymphopenia, eosinopenia
🗑
|
||||
Fever | show 🗑
|
||||
Chronic inflammation | show 🗑
|
||||
show | cellular immunity; macrophages interact with TH1 class cells (memory cells)
🗑
|
||||
Positive PPD | show 🗑
|
||||
show | abscess; Staphylococcus aureus (coagulase)
🗑
|
||||
Cellulitis | show 🗑
|
||||
Pseudomembranous inflammation | show 🗑
|
||||
Cell cycle | show 🗑
|
||||
show | arrests cell in G1 phase for DNA repair or apoptosis
🗑
|
||||
show | stimulates apoptosis; activated by TP53 suppressor gene if too much DNA damage
🗑
|
||||
show | basement membrane, interstitial matrix
🗑
|
||||
Complete restoration | show 🗑
|
||||
Scar tissue | show 🗑
|
||||
Collagen | show 🗑
|
||||
show | cross-links at points of hydroxylation (lysyl oxidase) increase tensile strength
🗑
|
||||
Type I collagen | show 🗑
|
||||
show | early wound repair
🗑
|
||||
Type IV collagen | show 🗑
|
||||
Type X collagen | show 🗑
|
||||
show | key basement membrane glycoprotein
🗑
|
||||
Fibronectin | show 🗑
|
||||
Angiogenesis in repair | show 🗑
|
||||
Key event in wound repair | show 🗑
|
||||
Granulation tissue | show 🗑
|
||||
Collagenases | show 🗑
|
||||
Tensile strength of healed wound | show 🗑
|
||||
Inhibition wound healing | show 🗑
|
||||
show | defects in collagen synthesis and structure; hyperelasticity
🗑
|
||||
show | ↓ collagen tensile strength by decreasing cross-links at points of hydroxylation
🗑
|
||||
Keloid | show 🗑
|
||||
show | exuberant granulation tissue; bleeds when touched
🗑
|
||||
Healing by primary intention | show 🗑
|
||||
Healing by secondary intention | show 🗑
|
||||
show | regenerative nodules; abnormal cytoarchitecture
🗑
|
||||
show | type II pneumocyte repair cell
🗑
|
||||
CNS injury | show 🗑
|
||||
WBC alterations in acute inflammation | show 🗑
|
||||
show | increased fibrinogen enhances rouleaux
🗑
|
||||
C-reactive protein | show 🗑
|
||||
Polyclonal gammopathy | show 🗑
|
||||
show | ECF (plasma, interstitial fluid) + ICF (cytosol)
🗑
|
||||
Osmosis | show 🗑
|
||||
Edema | show 🗑
|
||||
show | protein and cell-poor fluid in interstitial space/body cavity; alteration Starling’s forces
🗑
|
||||
show | oncotic pressure (albumin) keeps fluid in vessels, hydrostatic pressure pushes fluid out
🗑
|
||||
Pitting edema | show 🗑
|
||||
show | pulmonary edema in LHF; pitting edema of legs in RHF; portal hypertension
🗑
|
||||
show | ↑ hydrostatic pressure and ↓ oncotic pressure
🗑
|
||||
Causes of renal retention of sodium/water | show 🗑
|
||||
show | kwashiorkor; nephrotic syndrome; cirrhosis
🗑
|
||||
Ascites in cirrhosis | show 🗑
|
||||
Exudate | show 🗑
|
||||
show | radical mastectomy; filariasis; inflammatory carcinoma (lymphatics plugged by tumor)
🗑
|
||||
show | endothelial injury, stasis, hypercoagulability
🗑
|
||||
show | fibrin clot with entrapped RBCs, WBCs, platelets; deep veins below knee (stasis)
🗑
|
||||
show | anticoagulants that prevent venous clot formation
🗑
|
||||
show | endothelial injury; platelets held together by fibrin
🗑
|
||||
show | prevents platelet thrombus in arteries
🗑
|
||||
show | femoral vein site of origin
🗑
|
||||
Systemic thromboembolism | show 🗑
|
||||
show | long bone fractures; delayed symptoms (48 hrs); thrombocytopenia, hypoxemia
🗑
|
||||
show | DIC; lanugo hair in maternal pulmonary arteries
🗑
|
||||
show | 1 atmosphere pressure increase with 33 foot descent into water; N2 gas dissolved in tissue
🗑
|
||||
show | release of N2 gas from tissue with rapid ascent; ischemic damage
🗑
|
||||
show | pulmonary embolus
🗑
|
||||
show | spontaneous pneumothorax
🗑
|
||||
Hypovolemic shock (blood loss) | show 🗑
|
||||
show | ↓ CO; ↑ LVEDP and PVR
🗑
|
||||
Septic shock | show 🗑
|
||||
show | most susceptible organ in shock; straight portion proximal tubule most susceptible
🗑
|
||||
show | ischemic ATN, multiorgan failure, ↑ AG metabolic acidosis
🗑
|
||||
show | parenchyma neoplastic component
🗑
|
||||
Benign tumors | show 🗑
|
||||
show | epithelial origin; squamous cell carcinoma, adenocarcinoma, transitional cell carcinoma
🗑
|
||||
show | invades but does not metastasize
🗑
|
||||
Squamous cell carcinoma | show 🗑
|
||||
Adenocarcinoma | show 🗑
|
||||
show | renal pelvis, ureter, bladder
🗑
|
||||
Sarcoma | show 🗑
|
||||
Liposarcoma | show 🗑
|
||||
Embryonal rhabdomyosarcoma | show 🗑
|
||||
show | ectoderm, endoderm, mesoderm derivatives; bone/teeth visible on x-ray
🗑
|
||||
Hamartoma | show 🗑
|
||||
Choristoma | show 🗑
|
||||
show | different morphologic patterns, same germ cell layer; pleomorphic adenoma parotid
🗑
|
||||
show | malignancy of stem cells in bone marrow
🗑
|
||||
show | malignancy of lymph nodes
🗑
|
||||
show | stomach (MC), Peyer’s patches
🗑
|
||||
Malignant tumors | show 🗑
|
||||
show | increases telomere length; found in all neoplastic cells
🗑
|
||||
Monoclonality | show 🗑
|
||||
E-Cadherin | show 🗑
|
||||
Malignant cells | show 🗑
|
||||
show | type IV collagenase (basement membrane)
🗑
|
||||
Angiogenesis | show 🗑
|
||||
show | lymphatic, hematogenous, seeding; often more common than primary cancer
🗑
|
||||
Carcinoma | show 🗑
|
||||
show | renal cell carcinoma (renal vein, vena cava), hepatocellular carcinoma
🗑
|
||||
Sarcoma | show 🗑
|
||||
Seeding | show 🗑
|
||||
Sites where metastasis more common primary cancer | show 🗑
|
||||
Sites where primary cancer more common than metastasis | show 🗑
|
||||
Bone metastasis | show 🗑
|
||||
Bone sites metastasis | show 🗑
|
||||
show | prostate cancer; increased serum AP, hypercalcemia
🗑
|
||||
show | breast cancer
🗑
|
||||
EM neurosecretory granules | show 🗑
|
||||
show | rhabdomyosarcoma
🗑
|
||||
show | histocytic neoplasms (Langerhan’s histiocytosis)
🗑
|
||||
Primary prevention | show 🗑
|
||||
Cancers in children | show 🗑
|
||||
Cancer vaccine | show 🗑
|
||||
show | prostate → lung → colorectal
🗑
|
||||
Cancer incidence women | show 🗑
|
||||
show | lung → prostate → colorectal
🗑
|
||||
show | lung → breast → colorectal
🗑
|
||||
Gynecologic cancers | show 🗑
|
||||
show | decreased incidence of cervical cancer; detects cervical dysplasia
🗑
|
||||
show | fastest increasing in world
🗑
|
||||
show | nasopharyngeal carcinoma (EBV)
🗑
|
||||
Southeast Asia | show 🗑
|
||||
show | stomach cancer
🗑
|
||||
show | Burkitt’s lymphoma, Kaposi sarcoma (HHV-8)
🗑
|
||||
Squamous dysplasia oropharynx, larynx, bronchus, cervix | show 🗑
|
||||
Chronic irritation sinus orifices, third degree burn scars | show 🗑
|
||||
Actinic (solar) keratosis | show 🗑
|
||||
Glandular metaplasia of esophagus (Barrett’s) | show 🗑
|
||||
Endometrial hyperplasia | show 🗑
|
||||
Glandular (intestinal) metaplasia of stomach (Helicobacter) | show 🗑
|
||||
show | risk factor for adenocarcinoma
🗑
|
||||
show | risk factor for adenocarcinoma
🗑
|
||||
Tubular adenoma of colon | show 🗑
|
||||
Scar tissue in lung | show 🗑
|
||||
Regenerative nodules in cirrhosis | show 🗑
|
||||
Complete hydatidiform mole | show 🗑
|
||||
Dysplastic mole | show 🗑
|
||||
show | MC risk factor for BCC, SCC, melanoma
🗑
|
||||
HHV-8 | show 🗑
|
||||
show | MC risk factor for nasopharyngeal carcinoma
🗑
|
||||
show | MC risk factor for larynx (SCC), lung cancers
🗑
|
||||
show | MC risk factor for mesothelioma
🗑
|
||||
Polycyclic hydrocarbons | show 🗑
|
||||
Barrett’s esophagus | show 🗑
|
||||
show | MC risk factor for stomach adenocarcinoma and lymphoma
🗑
|
||||
show | MC risk factors for colon adenocarcinoma
🗑
|
||||
show | MC risk factors for hepatocellular carcinoma
🗑
|
||||
Vinyl chloride | show 🗑
|
||||
Gallstones, porcelain gallbladder | show 🗑
|
||||
Polycyclic hydrocarbons | show 🗑
|
||||
Polycyclic hydrocarbons | show 🗑
|
||||
Polycyclic hydrocarbons | show 🗑
|
||||
show | MC risk factor for penis SCC
🗑
|
||||
Age | show 🗑
|
||||
show | MC risk factor for seminoma
🗑
|
||||
Age >50 with excess estrogen exposure | show 🗑
|
||||
HPV 16/18 | show 🗑
|
||||
DES | show 🗑
|
||||
Nulliparity | show 🗑
|
||||
show | MC risk factor for choriocarcinoma
🗑
|
||||
show | MC risk factor for dysgerminoma of ovary
🗑
|
||||
show | gonadoblastoma of ovary
🗑
|
||||
show | MC risk factor for papillary cancer of thyroid
🗑
|
||||
Family history (MEN IIa/IIb) | show 🗑
|
||||
show | MC risk factor for malignant lymphoma thyroid
🗑
|
||||
Ionizing radiation | show 🗑
|
||||
show | MC risk factor for primary CNS lymphoma in AIDS and Burkitt’s lymphoma
🗑
|
||||
show | MC risk factor for acute/chronic myelogenous leukemia
🗑
|
||||
EBV | show 🗑
|
||||
show | MC risk factor for T cell leukemia/lymphoma
🗑
|
||||
Bacterial causes of cancer | show 🗑
|
||||
Parasitic causes of cancer | show 🗑
|
||||
show | mutations involving regulatory genes
🗑
|
||||
show | proto-oncogenes, suppressor genes, anti-apoptosis genes
🗑
|
||||
Types mutations | show 🗑
|
||||
Translocations | show 🗑
|
||||
show | TP53 suppressor gene, RAS protooncogene
🗑
|
||||
show | inactivates suppressor genes (e.g., TP53), activates proto-oncogenes (e.g., RAS)
🗑
|
||||
Amplification | show 🗑
|
||||
Overexpression | show 🗑
|
||||
S/S POC | show 🗑
|
||||
show | function growth factor receptor; activation bad prognostic sign for breast carcinoma
🗑
|
||||
show | function-GTP signal transduction; point mutation; 30% of all human cancer
🗑
|
||||
ABL POC | show 🗑
|
||||
show | function nuclear transcription; translocation (8; 14) causing Burkitt’s lymphoma
🗑
|
||||
Inactivation suppressor genes | show 🗑
|
||||
Sporadic retinoblastoma | show 🗑
|
||||
show | one hit theory; one already inactivated in germ cells
🗑
|
||||
show | G,-S phase inhibition, DNA repair, activation BAX apoptosis gene
🗑
|
||||
Inactivation TP 53 suppressor gene | show 🗑
|
||||
RB suppressor gene function | show 🗑
|
||||
Inactivation RB suppressor gene | show 🗑
|
||||
show | prevents nuclear transcription by catenin
🗑
|
||||
Inactivation APC suppressor gene | show 🗑
|
||||
BRCA1/2 suppressor genes function | show 🗑
|
||||
show | breast, ovarian cancers
🗑
|
||||
show | anti apoptosis gene (keeps cytochrome c in mitochondria)
🗑
|
||||
show | t(14;18) translocation of heavy chain causes overexpression; follicular B cell lymphoma [think t(14;18) = t(l4;lB) for foLLicular B]
🗑
|
||||
show | AR; defect in DNA repair enzymes; ↑ risk for UVB light cancers
🗑
|
||||
show | AD; inactivation DNA mismatch genes; colorectal cancer
🗑
|
||||
show | AR; susceptibility to DNA damage; leukemias, lymphomas
🗑
|
||||
Examples chromosome instability | show 🗑
|
||||
show | chemicals (MC), viruses, radiation, H. pylori, physical (squamous cancer in bum scar)
🗑
|
||||
show | key chemical carcinogen (cigarette smoke)
🗑
|
||||
show | produced from Aspergillus; hepatocellular carcinoma
🗑
|
||||
Asbestos | show 🗑
|
||||
Thorium dioxide | show 🗑
|
||||
Aniline dyes | show 🗑
|
||||
Vinyl chloride | show 🗑
|
||||
Benzene | show 🗑
|
||||
show | transitional cell carcinoma of bladder
🗑
|
||||
EBV | show 🗑
|
||||
show | hepatocellular carcinoma
🗑
|
||||
HPV | show 🗑
|
||||
HHV-8 | show 🗑
|
||||
UVB cancers | show 🗑
|
||||
show | cytotoxic CD8 T cells (type IV hypersensitivity)
🗑
|
||||
Cachexia | show 🗑
|
||||
Most common anemia | show 🗑
|
||||
show | hypercoagulability
🗑
|
||||
Most common COD in cancer | show 🗑
|
||||
show |
🗑
|
||||
show | possible marker for lung cancer
🗑
|
||||
Non-bacterial thrombotic endocarditis mitral valve | show 🗑
|
||||
show | metastasis more important than nodal involvement
🗑
|
||||
show | hepatocellular carcinoma, yolk sac tumors
🗑
|
||||
show | prostate cancer
🗑
|
||||
CEA | show 🗑
|
||||
show | multiple myeloma
🗑
|
||||
β-human chorionic gonadotropin | show 🗑
|
||||
Calcitonin | show 🗑
|
||||
Small cell carcinoma lung | show 🗑
|
||||
show | EPO (polycythemia), PTH-related peptide (hypercalcemia)
🗑
|
||||
Hepatocellular carcinoma | show 🗑
|
||||
Medullary carcinoma of thyroid | show 🗑
|
||||
Squamous cell carcinoma of lung | show 🗑
|
||||
show | synthesized in peritubular capillaries
🗑
|
||||
show | measure of effective erythropoiesis; correct for degree of anemia
🗑
|
||||
Extramedullary hematopoiesis | show 🗑
|
||||
show | drop in Hb due to replacement of HbF RBCs with HbA
🗑
|
||||
Pregnancy | show 🗑
|
||||
Anemia | show 🗑
|
||||
show | average volume of RBCs; useful for anemia classification
🗑
|
||||
MCHC | show 🗑
|
||||
MCHC | show 🗑
|
||||
show | ↓ MCV, ↑ RBC count
🗑
|
||||
RDW | show 🗑
|
||||
Mature RBC | show 🗑
|
||||
show | ↑ iron deficiency; ↓ anemia chronic disease, sideroblastic anemia
🗑
|
||||
% Saturation | show 🗑
|
||||
show | ↓ iron deficiency; ↑ anemia chronic disease, sideroblastic anemia; normal thalassemia
🗑
|
||||
show | iron deficiency MC, anemic chronic disease, thalassemia, sideroblastic anemia
🗑
|
||||
show | MCC Meckel’s diverticulum
🗑
|
||||
Iron deficiency woman < 50 | show 🗑
|
||||
Iron deficiency man < 50 | show 🗑
|
||||
Iron deficiency men/woman > 50 | show 🗑
|
||||
Stages iron deficiency | show 🗑
|
||||
show | MC anemia in malignancy and alcoholics
🗑
|
||||
show | AR; two α-globin gene deletions; normal Hb electrophoresis
🗑
|
||||
HbH disease | show 🗑
|
||||
Hb Bart’s disease | show 🗑
|
||||
β-Thalassemia minor | show 🗑
|
||||
show | nonsense mutation with stop codon; hemolytic anemia; ↑↑ HbF, ↑ HbA2
🗑
|
||||
show | defect in mitochondrial heme synthesis producing ringed sideroblasts
🗑
|
||||
show | alcohol, pyridoxine deficiency (isoniazid Rx of TB), Pb poisoning
🗑
|
||||
show | inhibition ferrochelatase, d-aminolevulinic acid dehydrase, ribonuclease
🗑
|
||||
show | growth retardation; Pb in epiphyses (lead lines); abdominal colic; encephalopathy
🗑
|
||||
show | peripheral neuropathy; proximal renal tubule damage (Fanconi’s syndrome)
🗑
|
||||
show | coarse basophilic stippling RBCs; ↓ MCV; ↑ blood Pb; ↑ d-aminolevulinic acid
🗑
|
||||
Vitamin B12 | show 🗑
|
||||
show | transfers methyl group to homocysteine
🗑
|
||||
R factor | show 🗑
|
||||
Vitamin B12 | show 🗑
|
||||
show | vegan, pernicious anemia MC, fish tapeworm, pancreatitis, bacterial overgrowth, Crohn’s disease
🗑
|
||||
Pernicious anemia | show 🗑
|
||||
Causes folate deficiency | show 🗑
|
||||
Drugs and folate deficiency | show 🗑
|
||||
show | inhibited by phenytoin
🗑
|
||||
show | inhibited by alcohol and OC
🗑
|
||||
Dihydrofolate reductase | show 🗑
|
||||
Thymidylate synthetase | show 🗑
|
||||
show | MCC of increased serum homocysteine
🗑
|
||||
Lab in B12/folate deficiency | show 🗑
|
||||
Lab findings unique to B12 deficiency | show 🗑
|
||||
show | PA
🗑
|
||||
B12 reabsorbed absorbed after administration of antibiotics | show 🗑
|
||||
B12 reabsorbed absorbed after administration of pancreatic extract | show 🗑
|
||||
show | initially normal Hb and Hct; 0.9% saline uncovers RBC deficit
🗑
|
||||
Aplastic anemia | show 🗑
|
||||
show | pancytopenia; hypocellular bone marrow
🗑
|
||||
Anemia in renal disease | show 🗑
|
||||
Extravascular hemolysis | show 🗑
|
||||
show | ↓ serum haptoglobin; hemoglobinuria; hemosiderinuria
🗑
|
||||
show | AD; defect in spectrin; extravascular hemolysis; splenomegaly
🗑
|
||||
show | normocytic anemia; dense RBCs, ↑ MCHC, ↑ osmotic fragility
🗑
|
||||
show | missing decay accelerating factor; complement destruction RBCs, neutrophils, platelets
🗑
|
||||
S/S PNH | show 🗑
|
||||
HbSS | show 🗑
|
||||
show | ↑ deoxyhemoglobin (hypoxemia, acidosis); HbS > 60%
🗑
|
||||
show | inhibits sickling; hydroxyurea ↑ HbF
🗑
|
||||
show | vasoocclusive crises, hemolytic anemia (extravascular)
🗑
|
||||
HbSS children | show 🗑
|
||||
HbSS osteomyelitis | show 🗑
|
||||
show | aplastic crisis (parvovirus B-19), acute chest syndrome, autosplenectomy, calcium bilirubinate gallstones, priapism, aseptic necrosis
🗑
|
||||
HbAS | show 🗑
|
||||
show | HbAS-HbA 55-60%, HbS 40-45%; HbSS-HbS 90-95%, HbF 5-10%
🗑
|
||||
Blood findings in HbSS | show 🗑
|
||||
G6PD deficiency | show 🗑
|
||||
Blood findings G6PD deficiency | show 🗑
|
||||
show | ↓ ATP; RBCs dehydrated; ↑ 2,3-BPG (right-shifted OBC)
🗑
|
||||
Warm type AIHA | show 🗑
|
||||
show | IgM intravascular hemolysis; e.g., CLL, Mycoplasma
🗑
|
||||
Penicillin | show 🗑
|
||||
show | drug alters Rh antigens; IgG antibody against Rh antigens (type II hypersensitivity)
🗑
|
||||
show | drug-IgM IC; intravascular hemolysis; type III hypersensitivity
🗑
|
||||
Lab findings AIHA | show 🗑
|
||||
show | mechanical damage causing intravascular hemolysis
🗑
|
||||
Causes of micro/macro hemolysis | show 🗑
|
||||
show | schistocytes; iron deficiency from hemoglobinuria
🗑
|
||||
Malaria | show 🗑
|
||||
show | exaggerated WBC response to infection; usually due to infection
🗑
|
||||
Leukoerythroblastic reaction | show 🗑
|
||||
show | bone metastasis MCC, myelofibrosis
🗑
|
||||
Eosinophilia | show 🗑
|
||||
Helminthes not producing eosinophilia | show 🗑
|
||||
show | mononucleosis; CMV; toxoplasmosis; viral hepatitis; phenytoin
🗑
|
||||
Mononucleosis | show 🗑
|
||||
Clinical findings mono | show 🗑
|
||||
Lab findings mono | show 🗑
|
||||
show | T cell deficiencies (HIV); combined B/T deficiency (adenine deaminase deficiency)
🗑
|
||||
show | viral infections, whooping cough
🗑
|
||||
show | lymphopenia, eosinopenia, neutrophilia
🗑
|
||||
show | neoplastic stem cell disorder; splenomegaly; marrow fibrosis; risk for leukemia
🗑
|
||||
Examples of MPD | show 🗑
|
||||
Relative polycythemia | show 🗑
|
||||
show | ↓ RBC count and RBC mass
🗑
|
||||
show | hypoxic stimulus for EPO to generate RBCs
🗑
|
||||
Causes of appropriate absolute polycythemia | show 🗑
|
||||
show | normal plasma volume; ↑ RBC mass; ↓ SaO2; ↑ EPO
🗑
|
||||
Inappropriate absolute polycythemia | show 🗑
|
||||
Causes of inappropriate polycythemia | show 🗑
|
||||
Polycythemia vera | show 🗑
|
||||
Ectopic EPO (renal cell carcinoma) | show 🗑
|
||||
Myelofibrosis myeloid metaplasia | show 🗑
|
||||
show | tear drop RBCs; dry bone marrow aspirate (marrow fibrosis)
🗑
|
||||
show | MPO with increase in abnormal appearing platelets
🗑
|
||||
show | severe anemia in elderly; 30% develop leukemia; ringed sideroblasts
🗑
|
||||
Benzene | show 🗑
|
||||
show | ALL, newborn-14; AML, 15-60; CML, 40-60; CLL, >60
🗑
|
||||
show | acute, blasts >30% in bone marrow; chronic, blasts <10% in bone marrow
🗑
|
||||
show | Auer rods in myeloblasts
🗑
|
||||
Acute promyelocytic leukemia | show 🗑
|
||||
show | gum infiltration
🗑
|
||||
CML | show 🗑
|
||||
ALL | show 🗑
|
||||
show | t(12;21) offers good prognosis
🗑
|
||||
CLL | show 🗑
|
||||
Adult T cell leukemia | show 🗑
|
||||
Hairy cell leukemia | show 🗑
|
||||
Nodal sites | show 🗑
|
||||
Testicular cancer | show 🗑
|
||||
Stomach cancer | show 🗑
|
||||
Phenytoin | show 🗑
|
||||
show | Bartonella henselae; granulomatous microabscesses
🗑
|
||||
show | t(14;18); overexpression of BCL-2 anti-apoptosis gene
🗑
|
||||
show | t(8;14); EBV association; common childhood NHL; “starry sky” appearance
🗑
|
||||
show | risk factors H. pylori (stomach); Sjogren’s syndrome
🗑
|
||||
show | CD4 T cell neoplasm; skin lesions with Pautrier’s microabscesses
🗑
|
||||
show | leukemic phase of mycosis fungoides
🗑
|
||||
show | sign of chronic inflammation
🗑
|
||||
Monoclonal gammopathy | show 🗑
|
||||
Confirmatory tests | show 🗑
|
||||
Bence Jones protein | show 🗑
|
||||
Multiple myeloma | show 🗑
|
||||
MGUS | show 🗑
|
||||
show | elderly patient; no BJ protein; no malignant plasma cells
🗑
|
||||
show | lymphoplasmacytic lymphoma; IgM M spike; hyperviscosity
🗑
|
||||
show | neoplastic component, Reed Stemberg (RS) cell; CD15 CD30 positive
🗑
|
||||
show | infrequent classic RS cells
🗑
|
||||
show | female dominant; supraclavicular nodes + anterior mediastinal nodes
🗑
|
||||
Mixed cellularity Hodgkin’s | show 🗑
|
||||
Hodgkin’s prognosis | show 🗑
|
||||
show | ↑ risk for second malignancies (leukemia; NHL)
🗑
|
||||
show | CD1 positive; Birbeck granules
🗑
|
||||
show | malignant histiocytosis <2 yrs old; diffuse eczematous rash; organ involvement
🗑
|
||||
Hand-Christian-Christian disease | show 🗑
|
||||
show | benign histiocytosis; lytic bone lesions with pathologic fractures
🗑
|
||||
Mast cells | show 🗑
|
||||
Urticaria pigmentosum | show 🗑
|
||||
show | twisted β-sheet; apple green birefringence with Congo red
🗑
|
||||
Primary amyloidosis | show 🗑
|
||||
show | AA amyloid derived from serum-associated amyloid; chronic infections
🗑
|
||||
Alzheimer’s disease | show 🗑
|
||||
Gaucher’s disease | show 🗑
|
||||
Niemann Pick’s disease | show 🗑
|
||||
Hypersplenism | show 🗑
|
||||
Splenic dysfunction | show 🗑
|
||||
show | tissue plasminogen activator, heparin, PGI2 ATIII, protein C/S
🗑
|
||||
show | enhances ATIII activity (neutralizes all factors except V, VIII, fibrinogen)
🗑
|
||||
Protein C/S | show 🗑
|
||||
show | coagulation factors, thromboxane A2 (platelet aggregation, vasoconstrictor)
🗑
|
||||
Protein C and S | show 🗑
|
||||
show | complexes with factor VIII to enhance VIII:C activity; platelet adhesion
🗑
|
||||
Platelets | show 🗑
|
||||
show | platelet receptor for von Willebrand factor
🗑
|
||||
show | platelet receptor for fibrinogen
🗑
|
||||
show | VII
🗑
|
||||
show | XII, XI, IX, VIII
🗑
|
||||
show | X, V, prothrombin (II), fibrinogen (I)
🗑
|
||||
Factor XIII | show 🗑
|
||||
Vitamin K-dependent factors | show 🗑
|
||||
show | fibrinogen, prothrombin, V, VIII; fluid is called serum
🗑
|
||||
show | cleaves fibrinogen and insoluble fibrin into degradation products
🗑
|
||||
Bleeding time | show 🗑
|
||||
show | MCC of a prolonged bleeding time
🗑
|
||||
Tests for vWF | show 🗑
|
||||
show | evaluates extrinsic pathway to fibrin clot
🗑
|
||||
show | evaluates intrinsic pathway to stable fibrin clot
🗑
|
||||
show | fibrin(ogen) degradation products; D-dimers (cross-linked insoluble fibrin)
🗑
|
||||
S/S platelet dysfunction | show 🗑
|
||||
Idiopathic thrombocytopenic purpura (ITP) | show 🗑
|
||||
Chronic autoimmune thrombocytopenic purpura | show 🗑
|
||||
show | thrombocytopenia due to IgG antibody against heparin attached to PF4 on platelets
🗑
|
||||
PF4 | show 🗑
|
||||
show | thrombocytopenia MC hematologic abnormality; similar to ITP
🗑
|
||||
TTP | show 🗑
|
||||
show | fever, thrombocytopenia, renal failure, hemolytic anemia with schistocytes, CNS deficits
🗑
|
||||
show | thrombocytopenia, prolonged bleeding time, normal PT and PTT
🗑
|
||||
show | similar to TTP; endothelial injury from Shiga-like toxin of 0157:H7 E. coli in undercooked beef
🗑
|
||||
S/S factor deficiency | show 🗑
|
||||
show | XR; hemarthroses; prolonged PTT, ↓ factor VIII activity, normal VIII antigen
🗑
|
||||
show | AD; platelet adhesion defect + factor VIII deficiency
🗑
|
||||
show | ↓ vWF, VIII antigen, and VIII:C; prolonged bleeding time
🗑
|
||||
Desmopressin acetate | show 🗑
|
||||
show | antibodies destroy coagulation factors
🗑
|
||||
show | prolonged PT and/or PTT corrected with mixing studies
🗑
|
||||
Vitamin K deficiency | show 🗑
|
||||
show | antibiotics MC, newborn, malabsorption, warfarin
🗑
|
||||
show | activation coagulation system from release of tissue thromboplastin and/or endothelial cell damage
🗑
|
||||
DIC | show 🗑
|
||||
show | septic shock MCC, rattlesnake bite, massive trauma, amniotic fluid
🗑
|
||||
show | bleeding from all scratches, holes, needle sites
🗑
|
||||
show | thrombocytopenia, ↑ PT and PTT, D-dimers (best test), anemia
🗑
|
||||
show | lupus anticoagulant and anticardiolipin antibodies; vessel thrombosis
🗑
|
||||
Warfarin | show 🗑
|
||||
Warfarin | show 🗑
|
||||
show | ingredient in rat poison; danger to children in households with grandparents on warfarin
🗑
|
||||
show | intramuscular vitamin K (6-8 hrs), fresh frozen plasma (immediate)
🗑
|
||||
show | enhances ATIII; PTT best test but PT also prolonged
🗑
|
||||
OC | show 🗑
|
||||
show | MC hereditary thrombosis; resistant to degradation by protein C/S
🗑
|
||||
ATIII deficiency | show 🗑
|
||||
Hemorrhagic skin necrosis | show 🗑
|
||||
show | specialized cells that transfer foreign antigens to lymphocytes in Peyer’s patches
🗑
|
||||
show | some patients have anti-AB-IgG antibodies; increased incidence duodenal ulcers
🗑
|
||||
show | increased incidence of gastric carcinoma
🗑
|
||||
Newborns | show 🗑
|
||||
show | may lose natural blood group antibodies; no hemolytic reaction to mismatched blood
🗑
|
||||
Rh antigens | show 🗑
|
||||
show | antibodies against Rh or non-Rh blood group antigens (e.g., anti-D)
🗑
|
||||
show | receptor for Plasmodium vivax; blacks often lack Duffy antigen
🗑
|
||||
show | indirect Coomb’s test; detects atypical antibodies in serum
🗑
|
||||
Cytomegalovirus | show 🗑
|
||||
Hepatitis C | show 🗑
|
||||
Major crossmatch | show 🗑
|
||||
Universal donor | show 🗑
|
||||
show | blood group AB; no natural blood group antibodies in serum
🗑
|
||||
show | raises Hb by 1 gm/dL and Hct by 3%
🗑
|
||||
Cryoprecipitate | show 🗑
|
||||
show | replacement for multiple factor deficiencies (e.g., cirrhosis, DIC)
🗑
|
||||
show | type I IgE-mediated hypersensitivity reaction
🗑
|
||||
show | recipient anti-HLA antibodies react against donor leukocytes
🗑
|
||||
Intravascular HTR | show 🗑
|
||||
Extravascular HTR | show 🗑
|
||||
Positive direct Coomb’s test | show 🗑
|
||||
show | jaundice, no increase in Hb, hemoglobinuria
🗑
|
||||
ABO HDN | show 🗑
|
||||
show | positive direct Coomb’s test; spherocytes; MCC unconjugated hyperbilirubinemia first 24 hrs
🗑
|
||||
show | mother Rh (D antigen) negative and fetus Rh (O antigen) positive
🗑
|
||||
show | no hemolysis in first Rh incompatible pregnancy
🗑
|
||||
show | maternal anti-D crosses placenta; potential for hydrops fetalis; high risk for kernicterus
🗑
|
||||
show | anti-D; coats D antigen site on fetal RBCs in maternal circulation
🗑
|
||||
Rh HDN lab | show 🗑
|
||||
show | protects mother from Rh sensitization (development of anti-D antibodies)
🗑
|
||||
show | A+ cells destroyed by mothers anti A-lgM
🗑
|
||||
Blue fluorescent light | show 🗑
|
||||
MV auscultation | show 🗑
|
||||
show | left parasternal border
🗑
|
||||
AV auscultation | show 🗑
|
||||
show | left 2nd intercostal space
🗑
|
||||
S1 | show 🗑
|
||||
S2 | show 🗑
|
||||
Inspiration | show 🗑
|
||||
show | abnormal; due to blood entering volume overloaded ventricle in early diastole
🗑
|
||||
Causes S3 | show 🗑
|
||||
show | abnormal; due to blood entering non-compliant ventricle with atrial contraction in late diastole
🗑
|
||||
show | volume overloaded ventricle, hypertrophy
🗑
|
||||
Murmurs | show 🗑
|
||||
Inspiration | show 🗑
|
||||
show | increases left sided abnormal heart sounds and murmurs
🗑
|
||||
show | problem in opening valve
🗑
|
||||
show | problem in closing valve
🗑
|
||||
Valves opening in systole | show 🗑
|
||||
show | MV and TV
🗑
|
||||
show | MV and TV
🗑
|
||||
Valves closing in diastole | show 🗑
|
||||
show | primary vehicle for carrying cholesterol
🗑
|
||||
VLDL | show 🗑
|
||||
Familial hypercholesterolemia (type II) | show 🗑
|
||||
show | deficiency apo E; ↑ remnants (chylomicron, intermediate density)
🗑
|
||||
show | ↑ VLDL; alcoholics
🗑
|
||||
show | deficiency apo B48 (chylomicrons) and B100 (VLDL); ↓ CH and TG
🗑
|
||||
Clinical findings in apo B deficiency | show 🗑
|
||||
show | reaction to injury of endothelial cells
🗑
|
||||
Risk factors | show 🗑
|
||||
Cells involved | show 🗑
|
||||
show | pathognomonic lesion of atherosclerosis
🗑
|
||||
show | marker of an inflammatory atheromatous plaque
🗑
|
||||
Inflammatory atheromatous plaque | show 🗑
|
||||
show | ↑ vessel thrombosis; folate (MC)/vitamin B12 deficiency
🗑
|
||||
show | small vessel disease of DM and hypertension; excess protein in vessel wall
🗑
|
||||
show | non-enzymatic glycosylation
🗑
|
||||
show | glucose attaches to amino acids in BM; causes ↑ permeability to protein
🗑
|
||||
Mechanisms hyaline arteriolosclerosis in hypertension | show 🗑
|
||||
show | due to atherosclerosis; flank pain, hypotension, pulsatile mass
🗑
|
||||
Syphilitic aneurysm | show 🗑
|
||||
show | due to hypertension and collagen tissue disorders (e.g., Marfan)
🗑
|
||||
show | elastic tissue degeneration creates spaces filled with mucopolysaccharides
🗑
|
||||
show | due to wall stress from hypertension and structural weakness
🗑
|
||||
show | proximal (MC); distal or combination of both
🗑
|
||||
show | chest pain radiating to back, lack of pulse; cardiac tamponade MC COD
🗑
|
||||
show | AD; fibrillin defect; aortic regurgitation/dissection; lens dislocation; MVP with sudden death
🗑
|
||||
MC COD Marfan’s and Ehlers Danlos | show 🗑
|
||||
Phlebothrombosis | show 🗑
|
||||
show | emboli originate from femoral veins
🗑
|
||||
Superficial migratory thrombophlebitis | show 🗑
|
||||
Thoracic outlet syndrome | show 🗑
|
||||
show | lymphedema hands/feet in newborn; preductal coarctation
🗑
|
||||
Spider telangiectasia | show 🗑
|
||||
Capillary hemangioma in newborn | show 🗑
|
||||
show | HHV-8; vascular malignancy; MC cancer in AIDS
🗑
|
||||
Bacillary angiomatosis | show 🗑
|
||||
show | palpable purpura; e.g., Henoch Schonlein purpura
🗑
|
||||
Muscular artery vasculitis | show 🗑
|
||||
show | absent pulse, stroke
🗑
|
||||
Takayasu’s arteritis | show 🗑
|
||||
Giant cell arteritis | show 🗑
|
||||
Classical polyarteritis nodosa | show 🗑
|
||||
Path findings | show 🗑
|
||||
S/S | show 🗑
|
||||
Diagnosis | show 🗑
|
||||
show | coronary artery vasculitis/thrombosis/aneurysms in children
🗑
|
||||
S/S | show 🗑
|
||||
Rx | show 🗑
|
||||
Buerger’s disease (thromboangiitis obliterans) | show 🗑
|
||||
show | digital vasculitis in PSS and CREST syndrome
🗑
|
||||
S/S | show 🗑
|
||||
Cryoglobulinemia | show 🗑
|
||||
S/S | show 🗑
|
||||
show | association with c-ANCA; sinusitis, lung infarction, crescentic GN
🗑
|
||||
Microscopic polyangiitis | show 🗑
|
||||
show | IgA-anti-IgA ICs; palpable purpura buttocks/legs; arthritis; IgA GN
🗑
|
||||
Serum sickness vasculitis | show 🗑
|
||||
show | tick borne
🗑
|
||||
show |
🗑
|
||||
show | sepsis causes petechia/ecchymoses; potential for Waterhouse Friderichsen syndrome
🗑
|
||||
Essential HTN blacks | show 🗑
|
||||
Renovascular HTN | show 🗑
|
||||
S/S | show 🗑
|
||||
show | 1º HPTH, Graves/hypothyroidism, Cushing’s, 1º aldosteronism, phaeochromocytoma
🗑
|
||||
show | LVH MC complication; AMI MC COD followed by stroke and renal failure
🗑
|
||||
show | resistance ventricles contract against
🗑
|
||||
show | volume ventricles must eject
🗑
|
||||
Concentric LVH | show 🗑
|
||||
show | increased preload; e.g., valve regurgitation; left to right shunts
🗑
|
||||
show | forward failure; pulmonary edema, pillow orthopnea, paroxysmal nocturnal dyspnea
🗑
|
||||
Systolic dysfunction | show 🗑
|
||||
show | LHF due to decreased ventricular compliance (hypertrophy)
🗑
|
||||
show | backward failure; ↑ venous hydrostatic pressure; neck vein distention, hepatomegaly, edema
🗑
|
||||
ACE inhibitors | show 🗑
|
||||
show | reduce preload
🗑
|
||||
Non-pharmacologic Rx in CHF | show 🗑
|
||||
show | MC COD in United States; left anterior descending coronary artery thrombosis MCC
🗑
|
||||
Exertional angina | show 🗑
|
||||
show | coronary artery vasospasm; transmural ischemia; ST elevation
🗑
|
||||
Sudden cardiac death | show 🗑
|
||||
Path findings | show 🗑
|
||||
show | anterior portion left ventricle, anterior 2/3rds IVS
🗑
|
||||
show | posterior portion left ventricle and papillary muscle, inferior 1/3rd IVS, right ventricle
🗑
|
||||
AMI | show 🗑
|
||||
Ventricular fibrillation | show 🗑
|
||||
AMI | show 🗑
|
||||
show | retrosternal pain radiating down arms, diaphoresis
🗑
|
||||
AMI ruptures | show 🗑
|
||||
Anterior wall rupture | show 🗑
|
||||
show | RCA thrombosis; mitral regurgitation with LHF
🗑
|
||||
IVS rupture | show 🗑
|
||||
Mural thrombus | show 🗑
|
||||
Pericarditis | show 🗑
|
||||
show | friction rub; leaning forward relieves pain
🗑
|
||||
show | late manifestation of AMI; precordial systolic bulge; CHF MC COD
🗑
|
||||
show | RCA thrombosis; hypotension, RHF, preserved left ventricular function
🗑
|
||||
show | CK-MB and troponins; CK-MB absent by 3 days; troponins last 7-10 days
🗑
|
||||
show | no longer used; LDH 1/2 flip indicates AMI
🗑
|
||||
show | reappearance CK-MB after 3 days
🗑
|
||||
ECG findings in AMI | show 🗑
|
||||
show | EF = stroke volume/left ventricular end-diastolic volume; 80/120 = 0.66
🗑
|
||||
show | use internal mammary artery and saphenous veins (“arterialize” after 10 yrs)
🗑
|
||||
Angioplasty complication | show 🗑
|
||||
show | highest O2 saturation
🗑
|
||||
show | shunts blood from pulmonary artery to aorta; PGE keeps it open
🗑
|
||||
Ductus arteriosus in newborn | show 🗑
|
||||
show | cyanosis due to reversal of left to right shunt
🗑
|
||||
show | MC congenital heart disease; ↑ SaO2 right ventricle (RV), pulmonary artery (PA)
🗑
|
||||
ASD | show 🗑
|
||||
Down syndrome | show 🗑
|
||||
PDA | show 🗑
|
||||
show | degree of pulmonic stenosis determines if cyanosis is present
🗑
|
||||
show | ↓ left ventricle, aorta
🗑
|
||||
show | ASD and PDA are cardioprotective
🗑
|
||||
Complete transposition | show 🗑
|
||||
show | 2° polycythemia; infective endocarditis; metastatic abscesses
🗑
|
||||
show | Turner’s syndrome
🗑
|
||||
show | constriction distal to ligamentum arteriosum
🗑
|
||||
show | upper extremity HTN; claudication; rib-notching; activation RAA also causes HTN
🗑
|
||||
show | type II hypersensitivity; group A streptococcus pharyngeal infection
🗑
|
||||
show | sterile vegetations mitral valve (regurgitation); myocarditis with Aschoff nodule
🗑
|
||||
show | polyarthritis (MC), carditis, erythema marginatum, rheumatoid nodules, chorea
🗑
|
||||
show | chronic rheumatic fever; opening snap followed by mid-diastolic rumble
🗑
|
||||
show | left atrial dilation hypertrophy - atrial fibrillation, thrombus, pulmonary edema, RHF
🗑
|
||||
show | myxomatous degeneration of mitral valve; common in Marfan syndrome, Ehlers Danlos
🗑
|
||||
S/S | show 🗑
|
||||
MVP click/murmur close to S1 | show 🗑
|
||||
MVP click/murmur close to S2 | show 🗑
|
||||
show | pansystolic murmur; S3 and S4 common
🗑
|
||||
show | LHF, infective endocarditis, acute rheumatic fever
🗑
|
||||
Aortic stenosis | show 🗑
|
||||
show | worsens obstruction and increases murmur intensity
🗑
|
||||
show | decreases obstruction and decreases murmur intensity
🗑
|
||||
Causes | show 🗑
|
||||
show | bounding pulses; early diastolic blowing murmur
🗑
|
||||
show | diastolic murmur; regurgitant flow on anterior leaflet mitral valve
🗑
|
||||
show | sign for AV replacement
🗑
|
||||
Causes aortic regurgitation | show 🗑
|
||||
Tricuspid regurgitation | show 🗑
|
||||
Causes | show 🗑
|
||||
show | tricuspid regurgitation, pulmonic stenosis
🗑
|
||||
show | Streptococcus viridans MCC; Staphylococcus aureus MCC IVDA
🗑
|
||||
show | Staphylococcus epidermidis (coagulase negative)
🗑
|
||||
show | Streptococcus bovis
🗑
|
||||
show | IC vasculitis-Roth spot, splinter hemorrhages; regurgitant murmurs; metas1atic abscesses
🗑
|
||||
show | positive blood culture Libman Sacks endocarditis
🗑
|
||||
Coxsackievirus | show 🗑
|
||||
Parasitic cause myocarditis | show 🗑
|
||||
show | all chamber pressures are uniformally increased
🗑
|
||||
S/S | show 🗑
|
||||
Dx and Rx | show 🗑
|
||||
Pulsus paradoxus | show 🗑
|
||||
Constrictive pericarditis | show 🗑
|
||||
Congestive cardiomyopathy | show 🗑
|
||||
show | postpartum, cardiotoxic drugs, hypothyroidism, alcohol
🗑
|
||||
Hypertrophic cardiomyopathy | show 🗑
|
||||
Site of obstruction | show 🗑
|
||||
Effect decreased preload on systolic murmur | show 🗑
|
||||
Effect increased preload on systolic murmur | show 🗑
|
||||
Restrictive cardiomyopathy | show 🗑
|
||||
show | iron, amyloid, glycogen; sarcoidosis; tropical endocardial fibrosis
🗑
|
||||
show | benign tumor left atrium; embolization; syncope
🗑
|
||||
Cardiac rhabdomyoma | show 🗑
|
||||
show | hypokalemia; MCC diuretic therapy (e.g., thiazides; loop diuretics)
🗑
|
||||
show | hyperkalemia; MCC renal failure
🗑
|
||||
show | subendocardial ischemia (e.g., classical angina pectoris)
🗑
|
||||
ST elevation | show 🗑
|
||||
show | MC chronic arrhythmia; absent P waves; danger for embolization
🗑
|
||||
Ventricular premature beats | show 🗑
|
||||
Ventricular fibrillation | show 🗑
|
||||
Anterior AMI | show 🗑
|
||||
Inferior AMI | show 🗑
|
||||
Wolff-Parkinson-White | show 🗑
|
||||
Alveolar O2 calculation | show 🗑
|
||||
Increased A-a gradient | show 🗑
|
||||
show | total amount of air expelled after a maximal inspiration
🗑
|
||||
Forced expiratory volume/1 second (FEV1) | show 🗑
|
||||
show | cyanotic when breast feeding; turns pink when crying
🗑
|
||||
show | allergic (MC; adults only), aspirin, cystic fibrosis
🗑
|
||||
show | requires sweat test to exclude cystic fibrosis
🗑
|
||||
show | patient on aspirin (pain syndrome) with nasal polyps, asthma
🗑
|
||||
Obstructive sleep apnea (OSA) | show 🗑
|
||||
show | danger cor pulmonale; requires sleep test; Rx. O2 with continuous positive airway pressure
🗑
|
||||
show | maxillary sinusitis MC in adults; ethmoiditis MC in children; S. pneumoniae MC
🗑
|
||||
show | association with EBV; metastasize to cervical nodes
🗑
|
||||
show | smoking MCC; hoarseness; squamous cell carcinoma
🗑
|
||||
Resorption atelectasis | show 🗑
|
||||
show | ↓ percussion; absent fremitus, breath sounds; inspiratory lag; elevated diaphragm
🗑
|
||||
RDS | show 🗑
|
||||
show | synthesize surfactant (lecithin, phosphatidylcholine); stored in lamellar bodies
🗑
|
||||
Surfactant | show 🗑
|
||||
Causes RDS | show 🗑
|
||||
Maternal diabetes | show 🗑
|
||||
Complications RDS | show 🗑
|
||||
Typical community acquired pneumonia | show 🗑
|
||||
show | bronchopneumonia, lobar pneumonia
🗑
|
||||
show | productive cough; consolidation - ↓ percussion, ↑ tactile fremitus
🗑
|
||||
show | interstitial pneumonia; Mycoplasma pneumoniae MCC
🗑
|
||||
show | low grade fever, non-productive cough, no signs consolidation
🗑
|
||||
show | Pseudomonas, aeruginosa MCC (respirators); others - S. aureus, E. coli
🗑
|
||||
show | MCC common cold; hand to mouth transmission
🗑
|
||||
show | MCC pneumonia and bronchiolitis in child
🗑
|
||||
Parainfluenza virus | show 🗑
|
||||
show | basophilic intranuclear inclusion surrounded by halo
🗑
|
||||
show | superimposed pneumonia with S. aureus increases mortality
🗑
|
||||
Rubeola | show 🗑
|
||||
Chlamydia pneumoniae | show 🗑
|
||||
Chlamydia trachomatis | show 🗑
|
||||
Coxiella burnetii | show 🗑
|
||||
show | crowded condition; cold agglutinins; azithromycin
🗑
|
||||
Streptococcus pneumoniae pneumonia | show 🗑
|
||||
show | tension pneumatocysts in children with cystic fibrosis
🗑
|
||||
Corynebacterium diphtheriae | show 🗑
|
||||
Haemophilus influenzae | show 🗑
|
||||
show | croup, epiglottitis
🗑
|
||||
Pseudomonas aeruginosa | show 🗑
|
||||
Klebsiella pneumoniae | show 🗑
|
||||
Legionella pneumophila | show 🗑
|
||||
Mycobacterium tuberculosis | show 🗑
|
||||
Candida albicans | show 🗑
|
||||
show | pigeon excreta; narrow-based bud
🗑
|
||||
Aspergillus fumigatus | show 🗑
|
||||
show | non-septate; vessel invader; frontal lobe abscess in diabetic ketoacidosis
🗑
|
||||
show | Southwest deserts; inhale arthrospores in dust; spherule with endospores
🗑
|
||||
S/S | show 🗑
|
||||
Histoplasma capsulatum | show 🗑
|
||||
show | simulates TB; yeasts phagocytosed by macrophages
🗑
|
||||
Blastomyces dermatitidis | show 🗑
|
||||
Pneumocystis carinii | show 🗑
|
||||
Primary TB | show 🗑
|
||||
show | Ghon focus (subpleural caseation); Ghon complex (spread to hilar nodes)
🗑
|
||||
show | cavitating lesion in upper lobe; kidney MC extrapulmonary site
🗑
|
||||
Mycobacterium avium intracellulare (MAI) | show 🗑
|
||||
CF | show 🗑
|
||||
show | pneumonia, malabsorption, males sterile; + sweat test; P. aeruginosa pneumonia MC COD
🗑
|
||||
Lung abscess | show 🗑
|
||||
show | posterobasal segment right lower lobe
🗑
|
||||
Aspiration supine | show 🗑
|
||||
Aspiration right side | show 🗑
|
||||
Pulmonary thromboembolism | show 🗑
|
||||
show | branch of aorta/intercostal artery; protects against developing pulmonary infarction
🗑
|
||||
Saddle embolus | show 🗑
|
||||
S/S pulmonary infarction | show 🗑
|
||||
Dx | show 🗑
|
||||
show | pleuritic inflammation; pulmonary embolus, pneumonia, pneumothorax
🗑
|
||||
Pathogenesis pulmonary hypertension (PH) | show 🗑
|
||||
show | vasoconstriction pulmonary vessels; vasodilation cerebral vessels
🗑
|
||||
show | 1° lung disease (COPD, restrictive), recurrent emboli, mitral stenosis, OSA, left-right shunts
🗑
|
||||
show | PH + RVH
🗑
|
||||
S/S | show 🗑
|
||||
Restrictive lung disease | show 🗑
|
||||
show | ↓ all volumes and capacities; ↑ FEV1sec/FVC ratio
🗑
|
||||
show | RLD; non-cardiogenic pulmonary edema due to alveolar injury
🗑
|
||||
show | neutrophil destruction of type I and II pneumocytes; hyaline membranes
🗑
|
||||
Causes | show 🗑
|
||||
show | inhalation mineral dust causing interstitial fibrosis; particles <0.5 μm to reach alveoli
🗑
|
||||
show | pneumoconiosis + rheumatoid nodules in lungs
🗑
|
||||
show | “black lung” disease; progressive massive fibrosis; no increased incidence cancer or TB
🗑
|
||||
Silicosis | show 🗑
|
||||
show | roofing material, old buildings (9/11), pipe-fitter shipyard
🗑
|
||||
Ferruginous bodies | show 🗑
|
||||
show | benign pleural plaques (MC); bronchogenic carcinoma (MC cancer); mesothelioma
🗑
|
||||
show | malignancy of serosa; no smoking association
🗑
|
||||
show | RLD; MC non-infectious lung and liver granulomatous disease
🗑
|
||||
S/S | show 🗑
|
||||
Lab findings | show 🗑
|
||||
show | intradermal injection sarcoid antigens causes skin reaction
🗑
|
||||
Farmer’s lung | show 🗑
|
||||
show | RLD; reaction against nitrogen dioxide in fermenting corn
🗑
|
||||
show | RLD; reaction against cotton, linen, hemp products in textile industry
🗑
|
||||
show | RLD; anti-BM antibodies; begins in lungs and ends in renal failure
🗑
|
||||
Collagen vascular RLD | show 🗑
|
||||
Drugs RLD | show 🗑
|
||||
Obstructive lung disease | show 🗑
|
||||
Obstructive lung disease | show 🗑
|
||||
Obstructive lung disease | show 🗑
|
||||
Asthma | show 🗑
|
||||
show | expiratory wheezing (inflamed terminal bronchioles); LTC4,-D4,-E4 bronchoconstrictors
🗑
|
||||
Charcot-Leyden crystals | show 🗑
|
||||
show | initial respiratory alkalosis; respiratory acidosis requires intubation
🗑
|
||||
Emphysema | show 🗑
|
||||
Respiratory unit | show 🗑
|
||||
show | ↑ AP diameter; depressed diaphragms; vertical heart
🗑
|
||||
Pathogenesis | show 🗑
|
||||
show | destruction/distention respiratory bronchioles upper lobe in smokers; THINK
🗑
|
||||
Panacinar emphysema | show 🗑
|
||||
Paraseptal emphysema | show 🗑
|
||||
Lab findings | show 🗑
|
||||
show | productive cough 3 months/2 consecutive years; blue bloater (cyanosis)
🗑
|
||||
Site of obstruction | show 🗑
|
||||
Lab findings | show 🗑
|
||||
Bronchiectasis | show 🗑
|
||||
Causes | show 🗑
|
||||
show | absent dynein arm in cilia; sinusitis, infertility, bronchiectasis, situs inversus
🗑
|
||||
show | squamous cancer and small cell cancer; men > women
🗑
|
||||
Peripheral lung cancers | show 🗑
|
||||
Squamous lung cancer | show 🗑
|
||||
Small cell carcinoma | show 🗑
|
||||
Bronchioloalveolar carcinoma | show 🗑
|
||||
show | usually adenocarcinoma developing in old TB scar
🗑
|
||||
Bronchial carcinoid | show 🗑
|
||||
show | more common than primary cancer; breast cancer MCC
🗑
|
||||
Pancoast tumor | show 🗑
|
||||
S/S | show 🗑
|
||||
show | granuloma MCC
🗑
|
||||
show | primary lung cancer obstructs vessel; venous congestion
🗑
|
||||
show | thymoma; nodular sclerosing Hodgkin’s; teratomas
🗑
|
||||
Posterior mediastinal masses | show 🗑
|
||||
Myasthenia gravis | show 🗑
|
||||
Thymoma | show 🗑
|
||||
Pleural effusions | show 🗑
|
||||
Spontaneous pneumothorax | show 🗑
|
||||
show | pleuritic chest pain, dyspnea, tracheal shift ipsilateral side, absent breath sounds
🗑
|
||||
show | flap-like pleural tear; increased pleural cavity pressure; compression atelectasis
🗑
|
||||
S/S | show 🗑
|
||||
show | failure of fusion of facial processes
🗑
|
||||
show | multinucleated giant cell with acidophilic intranuclear inclusions on Tzanck prep
🗑
|
||||
Hairy leukoplakia | show 🗑
|
||||
show | bilateral parotitis; unilateral orchitis; ↑ amylase
🗑
|
||||
Diphtheria | show 🗑
|
||||
Congenital syphilis | show 🗑
|
||||
show | anaerobic gram + filamentous bacteria; complication extracted dental abscess
🗑
|
||||
S/S | show 🗑
|
||||
show | majority are viral; 20% group A streptococcus
🗑
|
||||
show | common in newborn; pre-AIDS defining lesion; yeasts and pseudohyphae
🗑
|
||||
Dental caries | show 🗑
|
||||
show | mucosal pigmentation; hamartomatous polyps
🗑
|
||||
show | biopsy to rule out squamous dysplasia or cancer
🗑
|
||||
Squamous cell carcinoma | show 🗑
|
||||
Smokeless tobacco | show 🗑
|
||||
Gum hyperplasia | show 🗑
|
||||
show | MC benign tumor of salivary glands; parotid MC site
🗑
|
||||
Mucoepidermoid carcinoma | show 🗑
|
||||
show | lesion obstructing esophagus; e.g., cancer, web
🗑
|
||||
Plummer-Vinson syndrome | show 🗑
|
||||
Dysphagia for solids and liquids | show 🗑
|
||||
TE fistula | show 🗑
|
||||
VATER syndrome | show 🗑
|
||||
Zenker’s diverticulum | show 🗑
|
||||
GERD | show 🗑
|
||||
GERD | show 🗑
|
||||
AIDS esophagitis | show 🗑
|
||||
show | glandular metaplasia distal esophagus in GERD
🗑
|
||||
show | precursor for adenocarcinoma, stricture
🗑
|
||||
show | dilated left gastric vein; sign of portal hypertension due to cirrhosis
🗑
|
||||
show | tear of distal esophagus from retching in alcoholic or bulimic
🗑
|
||||
Boerhaave’s syndrome | show 🗑
|
||||
show | pneumomediastinum (air in subcutaneous tissue)
🗑
|
||||
show | contain VIP - relaxes LES
🗑
|
||||
show | failure of LES relaxation (no VIP); absent ganglion cells in the myenteric plexus
🗑
|
||||
show | aperistalsis/dilation of esophagus; regurgitation of undigested food at night
🗑
|
||||
X-ray achalasia | show 🗑
|
||||
show | Chagas’ disease; leishmania destroy ganglion cells
🗑
|
||||
Distal adenocarcinoma esophagus | show 🗑
|
||||
Squamous cell carcinoma of esophagus | show 🗑
|
||||
show | sign of upper GI bleed; acid changes Hb to hematin; peptic ulcer disease MCC
🗑
|
||||
show | vomiting blood; peptic ulcers MCC
🗑
|
||||
Congenital pyloric stenosis | show 🗑
|
||||
show | NSAIDs MCC
🗑
|
||||
Mucous barrier stomach | show 🗑
|
||||
Type A chronic gastritis | show 🗑
|
||||
Type B chronic gastritis | show 🗑
|
||||
H. pylori | show 🗑
|
||||
show | lesser curvature pylorus and antrum; poor defense against acid; food aggravates pain
🗑
|
||||
Duodenal ulcer | show 🗑
|
||||
Perforated peptic ulcer | show 🗑
|
||||
show | giant rugal hyperplasia; protein loss from increased mucus
🗑
|
||||
Zollinger-Ellison syndrome | show 🗑
|
||||
S/S | show 🗑
|
||||
Hypergastrinemia | show 🗑
|
||||
show | MC benign tumor of stomach
🗑
|
||||
Intestinal type adenocarcinoma | show 🗑
|
||||
Diffuse type adenocarcinoma | show 🗑
|
||||
show | stomach MC site for extranodal lymphomas; H. pylori associated
🗑
|
||||
Malabsorption | show 🗑
|
||||
Causes bile salt deficiency | show 🗑
|
||||
show | failure to reabsorb xylose indicates small bowel disease
🗑
|
||||
Calcification of pancreas | show 🗑
|
||||
show | autoimmune disease; antibodies against gliadin in gluten; flat villi
🗑
|
||||
Celiac disease | show 🗑
|
||||
show | systemic infection; foamy macrophages with bacteria (PAS+ inclusions) in small bowel submucosa
🗑
|
||||
S/S | show 🗑
|
||||
show | Campylobacter jejuni MCC; positive fecal smear for leukocytes
🗑
|
||||
show | loss isotonic fluid; enterotoxins from E. coli and V. cholerae
🗑
|
||||
show | hypotonic loss fluid; laxatives, lactase deficiency
🗑
|
||||
show | MCC diarrhea in children
🗑
|
||||
show | MCC diarrhea in adults
🗑
|
||||
show | common cause diarrhea in AIDS; MCC cholecystitis and pancreatitis in AIDS
🗑
|
||||
show | preformed toxin causes food poisoning; culture food
🗑
|
||||
show | preformed toxin in fried rice and tacos; gram positive rods in stool
🗑
|
||||
Clostridium botulinum (adult) | show 🗑
|
||||
Clostridium botulinum (child) | show 🗑
|
||||
show | pseudomembranous colitis; post-antibiotics; toxin assay stool; Rx metronidazole
🗑
|
||||
Shigella sonnei | show 🗑
|
||||
Salmonella enteritidis | show 🗑
|
||||
Salmonella paratyphi | show 🗑
|
||||
Salmonella typhi | show 🗑
|
||||
show | gallbladder
🗑
|
||||
show | MCC intestinal TB in United States (swallow TB); Peyer’s patch site of infection
🗑
|
||||
Enterotoxigenic E. coli | show 🗑
|
||||
show | secretory diarrhea; toxin stimulates adenylate cyclase to produce cAMP
🗑
|
||||
show | solution must contain glucose to reabsorb Na+ (co-transport)
🗑
|
||||
show | mesenteric lymphadenitis; sepsis in iron overload states
🗑
|
||||
Entamoeba histolytica | show 🗑
|
||||
show | MCC diarrhea in AIDS; acid-fast oocysts
🗑
|
||||
Giardia lamblia | show 🗑
|
||||
Trichuris trichiura | show 🗑
|
||||
show | anal pruritus; urethritis in girls; no eosinophilia
🗑
|
||||
show | intestinal obstruction due to adult worms; no eosinophilia
🗑
|
||||
Necator americanus | show 🗑
|
||||
Strongyloides stercoralis | show 🗑
|
||||
Diphyllobothrium latum | show 🗑
|
||||
Signs of small bowel obstruction | show 🗑
|
||||
Radiograph small bowel obstruction | show 🗑
|
||||
MCC small bowel obstruction | show 🗑
|
||||
show | vomiting bile-stained fluid at birth; double bubble sign; Down syndrome
🗑
|
||||
Hirschsprung disease | show 🗑
|
||||
S/S | show 🗑
|
||||
show | Down syndrome; Chagas disease
🗑
|
||||
Intussusception | show 🗑
|
||||
Meconium ileus | show 🗑
|
||||
show | second MCC of small bowel obstruction; common in weight lifting
🗑
|
||||
Gallstone ileus | show 🗑
|
||||
show | MC due to sigmoid colon twisting around mesentery
🗑
|
||||
Direct inguinal hernia | show 🗑
|
||||
Umbilical hernia | show 🗑
|
||||
show | MC site for polyps, cancer, diverticula
🗑
|
||||
show | diffuse abdominal pain with bloody diarrhea
🗑
|
||||
show | embolism (atrial fibrillation), thrombosis SMA or SMV
🗑
|
||||
Ischemic colitis | show 🗑
|
||||
Mesenteric angina | show 🗑
|
||||
show | submucosal dilation of venules in cecum; cause of hematochezia
🗑
|
||||
show | massive loss of blood per rectum; diverticulosis MCC
🗑
|
||||
show | persistence omphalomesenteric duct
🗑
|
||||
show | bleeding MC (iron deficiency in children), diverticulitis
🗑
|
||||
Meckel’s diverticulitis | show 🗑
|
||||
show | diverticulitis MC complication; MCC hematochezia and fistula formation
🗑
|
||||
show | “left-sided acute appendicitis”
🗑
|
||||
show | mucosal/submucosal ulceration; starts in rectum; crypt abscess; ↑ risk adenocarcinoma
🗑
|
||||
S/S | show 🗑
|
||||
UC associations | show 🗑
|
||||
Crohn’s disease | show 🗑
|
||||
show | colicky pain and diarrhea; fistulas (anal, bowl to bowel)
🗑
|
||||
Carcinoid tumor | show 🗑
|
||||
Carcinoid syndrome | show 🗑
|
||||
show | precursor lesion colon cancer; size and number determine risk of malignancy
🗑
|
||||
show | greatest risk for colon cancer (30%); secrete mucus rich in protein and potassium
🗑
|
||||
Familial polyposis | show 🗑
|
||||
show | AD, polyposis plus osteomas and desmoid tumors
🗑
|
||||
show | AD, polyposis plus brain tumors
🗑
|
||||
show | second MC cancer and cancer killer in adults
🗑
|
||||
show | obstruct; MC location rectosigmoid
🗑
|
||||
Right-sided colorectal cancer | show 🗑
|
||||
show | due to lymphoid hyperplasia in children and obstruction by fecalith in adults
🗑
|
||||
External hemorrhoids | show 🗑
|
||||
show | bleed; prolapse out of rectum
🗑
|
||||
Urobilinogen (UBG) | show 🗑
|
||||
show | enterohepatic circulation to liver and kidney (color of urine)
🗑
|
||||
Alcoholic liver disease | show 🗑
|
||||
show | serum ALT>AST
🗑
|
||||
Cholestasis markers | show 🗑
|
||||
Unconjugated bilirubin | show 🗑
|
||||
show | water soluble; never normal in urine
🗑
|
||||
% CB <20% (unconjugated) | show 🗑
|
||||
Gilbert’s disease | show 🗑
|
||||
show | unconjugated hyperbilirubinemia; begins on day three
🗑
|
||||
% CB 20-50% | show 🗑
|
||||
% CB >50% | show 🗑
|
||||
Negative urine bilirubin + trace urobilinogen | show 🗑
|
||||
Positive urine bilirubin, absent urobilinogen | show 🗑
|
||||
show | hepatitis
🗑
|
||||
show | extravascular hemolytic anemia
🗑
|
||||
Markers of severity of liver disease | show 🗑
|
||||
show | protective antibodies; day care centers, jails, homosexuals, traveling; not chronic
🗑
|
||||
Hepatitis B | show 🗑
|
||||
Hepatitis C | show 🗑
|
||||
Hepatitis D | show 🗑
|
||||
Anti-HBs alone | show 🗑
|
||||
show | recovered from HBV
🗑
|
||||
HBsAg + HBeAg + HBVDNA + anti-HBc-IgM | show 🗑
|
||||
Anti HBc-IgM alone | show 🗑
|
||||
HBsAg + anti-HBc-IgM | show 🗑
|
||||
Fulminant hepatic failure | show 🗑
|
||||
show | E. coli in adults; S. pneumoniae in children; complication of ascites
🗑
|
||||
Granulomatous hepatitis | show 🗑
|
||||
Amebiasis | show 🗑
|
||||
show | Echinococcus granulosis; sheep dog definitive host; man intermediate host
🗑
|
||||
Schistosomiasis | show 🗑
|
||||
show | Clonorchis sinensis; ingesting encysted larvae in fish; cholangiocarcinoma
🗑
|
||||
Congestive hepatomegaly (centrilobular necrosis) | show 🗑
|
||||
show | Budd-Chiari syndrome; painful hepatomegaly; ascites; portal hypertension
🗑
|
||||
Portal vein thrombosis | show 🗑
|
||||
show | fatty change; alcoholic hepatitis; cirrhosis
🗑
|
||||
show | ↑ synthesis of glycerol 3P (substrate for TG synthesis)
🗑
|
||||
Hypoglycemia in alcoholics | show 🗑
|
||||
show | ↑ lactate, ↑ ßOHB (acetyl CoA converted to AcAc and then ßOHB)
🗑
|
||||
Primary biliary cirrhosis | show 🗑
|
||||
show | association with ulcerative colitis; MCC of cholangiocarcinoma
🗑
|
||||
Extrahepatic biliary atresia | show 🗑
|
||||
show | acetaminophen, isoniazid, halothane
🗑
|
||||
show | intrahepatic cholestasis
🗑
|
||||
show | intrahepatic cholestasis; hepatic adenoma (intraperitoneal hemorrhage)
🗑
|
||||
Methotrexate | show 🗑
|
||||
show | vinyl chloride
🗑
|
||||
Hemochromatosis | show 🗑
|
||||
S/S | show 🗑
|
||||
Lab | show 🗑
|
||||
show | AR disease; defect in copper excretion in bile and synthesis of ceruloplasmin
🗑
|
||||
show | cirrhosis, movement disorder (necrosis in putamen), Kayser Fleisher ring (Descemet’s membrane)
🗑
|
||||
Lab | show 🗑
|
||||
HELLP syndrome | show 🗑
|
||||
show | AR, cannot secrete AAT from liver cell; cirrhosis; hepatocellular carcinoma
🗑
|
||||
show | coma and microvesicular fatty change post viral infection; increased ammonia
🗑
|
||||
Cirrhosis | show 🗑
|
||||
show | alcohol (MC), HBV/HCV, hemochromatosis, Wilson’s, AAT deficiency, 1° biliary
🗑
|
||||
show | mental status changes; ↑ serum ammonia
🗑
|
||||
show | ascites; varices; splenomegaly; hemorrhoids; caput medusae
🗑
|
||||
Cause of ascites | show 🗑
|
||||
Rx | show 🗑
|
||||
show | gynecomastia; spider angiomas; female hair distribution
🗑
|
||||
Lab findings cirrhosis | show 🗑
|
||||
show | estrogen related (steroids, oral contraceptives); intraperitoneal hemorrhage
🗑
|
||||
Liver cancer | show 🗑
|
||||
show | chronic HBV and HCV MCC; ↑ AFP; hepatic/portal vein invasion
🗑
|
||||
show | primary sclerosing cholangitis MCC, C.C sinensis
🗑
|
||||
Pathogenesis of cholesterol stones | show 🗑
|
||||
show | sign of extravascular hemolytic anemia (spherocytosis, HbSS)
🗑
|
||||
show | stone impacted in cystic duct; right upper quadrant colicky pain with radiation to shoulder
🗑
|
||||
Chronic cholecystitis | show 🗑
|
||||
Gallbladder cancer | show 🗑
|
||||
Acute pancreatitis | show 🗑
|
||||
show | epigastric pain with radiation into back
🗑
|
||||
show | localized ileus of duodenum due to acute pancreatitis
🗑
|
||||
show | abdominal mass; persistence of ↑ serum amylase >1 week
🗑
|
||||
show | alcohol abuse, CF; malabsorption, pain, type I diabetes
🗑
|
||||
show | smoking MCC
🗑
|
||||
S/S | show 🗑
|
||||
show | inability to concentrate urine
🗑
|
||||
Fixed specific gravity | show 🗑
|
||||
show | normal urine
🗑
|
||||
show | obstructive jaundice
🗑
|
||||
show | hepatitis
🗑
|
||||
Negative urine bilirubin + increased urobilinogen | show 🗑
|
||||
Positive urine nitrite + positive urine leukocyte esterase | show 🗑
|
||||
Sterile pyuria | show 🗑
|
||||
show | ↑ BUN and creatinine; ↓ renal blood flow (e.g. heart failure, hypovolemia)
🗑
|
||||
show | ↑ BUN and creatinine due to intrinsic renal disease (acute tubular necrosis)
🗑
|
||||
show | ↑ BUN and creatinine due to obstruction to urine flow
🗑
|
||||
show | <15:1 (renal failure); >15:1 (prerenal or postrenal azotemia)
🗑
|
||||
show | ratio 10/1 - renal failure
🗑
|
||||
show | ratio 40/1 - prerenal azotemia or postrenal azotemia
🗑
|
||||
show | measures GFR
🗑
|
||||
show | important sign of renal dysfunction
🗑
|
||||
RBC casts | show 🗑
|
||||
WBC casts | show 🗑
|
||||
Fatty casts with Maltese crosses | show 🗑
|
||||
show | normal unless associated with proteinuria
🗑
|
||||
Renal tubular cell casts | show 🗑
|
||||
Waxy or broad casts | show 🗑
|
||||
show | hexagonal crystals
🗑
|
||||
Horseshoe kidney | show 🗑
|
||||
show | MC childhood cystic disease; abnormal development; flank mass
🗑
|
||||
Maternal oligohydramnios | show 🗑
|
||||
Adult polycystic kidney disease | show 🗑
|
||||
show | synthesize basement membrane
🗑
|
||||
Glomerular BM | show 🗑
|
||||
Nephritic syndrome | show 🗑
|
||||
show | proteinuria >3.5 g/day; ascites and pitting edema; fatty casts; fusion of podocytes
🗑
|
||||
Immunofluorescence | show 🗑
|
||||
show | MC GN; usually nephritic; episodic hematuria; mesangial IC (lgA-anti-IgA) deposits
🗑
|
||||
show | nephritic; subepithelial deposits; skin/pharyngeal infections; anti-DNAase B
🗑
|
||||
show | nephritic; subendothelial deposits; anti-DNA antibodies
🗑
|
||||
Crescentic GN | show 🗑
|
||||
Goodpasture’s | show 🗑
|
||||
show | young male with hemoptysis progressing to renal failure
🗑
|
||||
Minimal change disease (lipoid nephrosis) | show 🗑
|
||||
show | podocyte fusion; loss of negative charge in glomerular BM
🗑
|
||||
show | nephrotic syndrome; AIDS and IV heroin abuse
🗑
|
||||
Membranous GN | show 🗑
|
||||
show | HBV, ACE inhibitors, cancer
🗑
|
||||
show | nephrotic; subepithelial deposits; HCV association; tram tracks
🗑
|
||||
Type II MPGN | show 🗑
|
||||
DM nodular glomerulosclerosis | show 🗑
|
||||
show | nodules with collagen in mesangium; hyaline arteriolosclerosis of arterioles
🗑
|
||||
show | inhibit angiotensin II vasoconstriction of efferent arterioles
🗑
|
||||
show | XD hereditary nephritis with sensorineural hearing loss
🗑
|
||||
show | prerenal azotemia MCC; renal tubular cell casts; BUN:creatinine ratio <15:1
🗑
|
||||
Ischemic ATN | show 🗑
|
||||
show | aminoglycosides, IVP dye, Pb/mercury poisoning
🗑
|
||||
Nephrotoxic ATN | show 🗑
|
||||
show | prerenal azotemia, ATN, glomerulonephritis, postrenal azotemia
🗑
|
||||
show | vesicoureteral reflux with ascending infection; WBC casts, fever, flank pain
🗑
|
||||
Chronic pyelonephritis | show 🗑
|
||||
show | type I/IV reaction; e.g., penicillin
🗑
|
||||
show | ARF, fever, rash, eosinophilia, eosinophiluria, WBC casts
🗑
|
||||
Analgesic nephropathy | show 🗑
|
||||
Myeloma kidney | show 🗑
|
||||
show | prevent by giving allopurinol prior to chemotherapy
🗑
|
||||
CRF | show 🗑
|
||||
show | hypovitaminosis D (no 1-α-hydroxylase); produces osteomalacia
🗑
|
||||
Renal osteodystrophy CRF | show 🗑
|
||||
show | secondary HPTH with increased osteoclastic activity
🗑
|
||||
S/S CRF | show 🗑
|
||||
show | kidney of hypertension; shrunken kidneys due to hyaline arteriolosclerosis
🗑
|
||||
Malignant hypertension | show 🗑
|
||||
Renal findings | show 🗑
|
||||
Renal infarction | show 🗑
|
||||
show | renal stone MCC; atrophy of cortex/medulla; postrenal azotemia
🗑
|
||||
Renal stones | show 🗑
|
||||
S/S | show 🗑
|
||||
show | due to urease producing organisms (Proteus); alkaline urine pH; ammonia smell
🗑
|
||||
Angiomyolipoma | show 🗑
|
||||
show | smoking MCC; invasion renal vein/vena cava; lung, bone mets; yellow colored
🗑
|
||||
show | flank mass, hematuria; ectopic hormones (EPO, PTH related peptide), left-sided varicocele
🗑
|
||||
Renal pelvis transitional cell carcinoma | show 🗑
|
||||
Wilm’s tumor | show 🗑
|
||||
show | persistent urachus
🗑
|
||||
Retroperitoneal fibrosis | show 🗑
|
||||
show | abdominal wall defect + epispadias
🗑
|
||||
Bladder diverticula | show 🗑
|
||||
show | E. coli; females > males; no fever, flank pain, or WBC casts
🗑
|
||||
Bladder transitional cell carcinoma | show 🗑
|
||||
S/S | show 🗑
|
||||
Bladder adenocarcinoma | show 🗑
|
||||
Bladder squamous cell carcinoma | show 🗑
|
||||
show | ventral opening on penis due to failure closure of urethral folds
🗑
|
||||
show | dorsal opening on penis due to defect in genital tubercle
🗑
|
||||
Peyronie’s disease | show 🗑
|
||||
Priapism | show 🗑
|
||||
Squamous cell carcinoma penis | show 🗑
|
||||
show | undescended testis; risk for seminoma applies to cryptorchid testis and normal testis
🗑
|
||||
show | mumps usually unilateral (infertility uncommon)
🗑
|
||||
show | <35 - N. gonorrhoeae, C. trachomatis; >35 - E. coli, P. aeruginosa
🗑
|
||||
show | scrotal pain relieved by elevation of scrotum (Prehn’s sign)
🗑
|
||||
Varicocele | show 🗑
|
||||
Varicocele | show 🗑
|
||||
show | persistent tunica vaginalis; scrotum transilluminates
🗑
|
||||
show | testicle high in canal; absent cremasteric reflex
🗑
|
||||
show | unilateral painless mass that does not transilluminate
🗑
|
||||
show | cryptorchid testis, Klinefelter’s, testicular feminization
🗑
|
||||
Seminoma | show 🗑
|
||||
Spermatocytic variant | show 🗑
|
||||
show | hemorrhage/necrosis; hematogenous spread before lymphatic; ↑AFP, hCG
🗑
|
||||
show | MC testicular cancer in boys; ↑AFP
🗑
|
||||
Choriocarcinoma | show 🗑
|
||||
show | more often benign in children than adult
🗑
|
||||
Teratocarcinoma | show 🗑
|
||||
show | MC type in elderly; metastasis not primary cancer
🗑
|
||||
show | DHT derived stimulation embryo; periurethral area - hyperplasia; peripheral area - cancer
🗑
|
||||
Prostatitis | show 🗑
|
||||
show | DHT/estrogen-mediated; glandular/smooth muscle hyperplasia
🗑
|
||||
S/S | show 🗑
|
||||
show | DHT-mediated; palpable with rectal exam; osteoblastic metastasis (↑ AP)
🗑
|
||||
PSA | show 🗑
|
||||
show | absent GnRH, anosmia, absence of taste
🗑
|
||||
Impotence | show 🗑
|
||||
show | parasympathetic response
🗑
|
||||
show | sympathetic response
🗑
|
||||
Leydig cell failure | show 🗑
|
||||
show | ↑ FSH (↓inhibin); ↓ sperm count; normal LH and testosterone
🗑
|
||||
show | ↑ FSH and LH; ↓ testosterone and sperm count
🗑
|
||||
show | determines genetic sex
🗑
|
||||
show | develops seminal vesicles, epididymis, vas deferens
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
megankirch
Popular USMLE sets